Delivery Order SPE2DB22D1017-SPE2DB25FF4HX

Award Date 1/29/25
Potential Completion Date 1/30/25
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order award from the Defense Logistics Agency (DLA) Troop Support Medical to the pharmaceutical distributor Amerisourcebergen Drug Corporation. The $2,446.67 fixed-price contract is for the supply of Valsartan-HCTZ 80-12.5 mg tablets. The contract has an ultimate completion date of July 19, 2024. This award is part of Amerisourcebergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999, for delivering a wide range of...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,332.06, is for the delivery of Valsartan-HCTZ 160-12.5 mg tablets. This is a firm fixed-price delivery order contract with an ultimate completion date of October 1, 2024. AmerisourceBergen is a significant supplier of pharmaceutical products and medical supplies to various government agencies, including the...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $37,776.53, is for the delivery of 90-count valsartan-HCTZ 160-12.5 mg tablets. This is a firm fixed-price delivery order contract with a completion date of May 1, 2023. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Valsartan-HCTZ 320-25 mg tablets. The contract has a ceiling value of $1,211.54 and is a firm fixed-price delivery order without a set-aside designation. The period of performance for this order extends to July 25, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,342.88, is for the delivery of Valsartan-HCTZ 160-12.5 mg tablets. It is a firm-fixed price delivery order contract with a period of performance through January 28, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Valsartan-HCTZ 160-12.5 mg tablets. The $4,965.21 firm fixed-price contract has an ultimate completion date of August 1, 2024. Amerisourcebergen has been awarded multiple indefinite delivery contracts (IDCs) by the DLA and Department of Justice worth up to $999,999,999 and $750,000, respectively, for providing a diverse range of...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,014.02, is for the delivery of Valsartan-HCTZ 320-12.5 mg tablets in 90-count packages. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of January 14, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Valsartan-HCTZ 80-12.5 mg tablets, a medication used to treat high blood pressure. The contract has a ceiling value of $12,311.92 and runs through January 2, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4,566,830,189 units of the pharmaceutical product Valsartan-HCTZ 160-12.5 mg tablets. The contract has a ceiling value of $1,611.65 and a period of performance through January 6, 2025. It is a firm-fixed-price contract, with no set-aside designation. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor. The $7,494.43 firm fixed-price contract is for the supply of Valsartan-HCTZ 160-25 mg tablets. This award is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB25FF4HX
    Delivery Order

This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Valsartan-HCTZ 160-12.5 mg tablets. The contract has a ceiling value of $1,108.14 and a performance period through January 30, 2025. AmerisourceBergen is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly the military and veterans' healthcare systems. This delivery order is part of a larger Indefinite Delivery Contract (IDC) the company holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award did not include any set-aside designation, indicating open competition.

Generated 4/30/25, 10:22 AM